LINDA VANOSDOL: Open Payments
NPI 1760922355 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 25 payments from 11 companies in 2025. Trend: 2023 $456 · 2024 $570 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| PFIZER INC. | 4 | $76 |
| Novo Nordisk Inc | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Lilly USA, LLC | 2 | $33 |
| Boston Scientific Corporation | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Abbott Laboratories | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: Kerendia, FARXIGA, Wegovy, PREVNAR 20, MOUNJARO, WATCHMAN Access System, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
